In human patients, cell-based assays and other animal model systems for AD, accumulation of Aβ42 plaques triggers cell death due to increased activity of the evolutionarily conserved c-Jun N-terminal Kinase (JNK) signaling pathway [8, 29, 33–39]. Here, MAPK8 is linked to Alzheimer disease.